Cargando...
Classical IL-6 signaling: a promising therapeutic target for pulmonary arterial hypertension
Current therapies for pulmonary arterial hypertension (PAH) provide symptomatic relief and improve prognosis but fall short of improving long-term survival. There is emerging evidence for a role of inflammatory mediators, primarily IL-6, in the pathogenesis of PAH. However, the mechanisms by which I...
Guardado en:
| Publicado en: | J Clin Invest |
|---|---|
| Autores principales: | , , |
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
American Society for Clinical Investigation
2018
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5919797/ https://ncbi.nlm.nih.gov/pubmed/29629898 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1172/JCI120415 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|